In our September 9 Front Row lecture, Giordano Lippi shares what his lab is learning about the role that tiny molecules called microRNAs play in brain development. With new insights, his team is developing novel tools for potentially treating genetic disorders of the developing brain. Take a seat and learn more!
Calibr has now identified and repurposed an FDA-approved drug, clofazimine, used for decades to treat leprosy, as a potential new treatment for cryptosporidiosis.